Comprehensive Cancer Center of Nevada

Las Vegas, Nevada 89169

We've found

3 trials

at this facility

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

Status: Enrolling
Updated: 8/31/2012

from

Las Vegas, NV

CAB-AXL-ADC Safety and Efficacy Study in Patients With Solid Tumors

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Las Vegas, NV

A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Las Vegas, NV

Use our guide to learn which trials are right for you!